Companies in #Mental Health Disorders
Found 1 company operating in this sector.
AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing treatments for mental health disorders, including psychedelic- and entactogen-based therapies for depression, anxiety, and opioid use disorder. The company was formed in November 2025 through the strategic combination of atai Life Sciences N.V. (founded 2018, publicly listed on Nasdaq since 2021) and Beckley Psytech Limited. Headquartered in New York, NY with primary research operations through its Berlin-based ATAI Life Sciences GmbH subsidiary, the company operates as the parent entity for both predecessor organizations' pipelines, with development programs spanning DMT-based therapies for treatment-resistant depression and a portfolio of additional psychedelic-derived compounds.